[18F]AlF-NOTA-PCP2

N/A

Report date: 2026/01/19 20:02:34

NME

Base Information

Drug Name[18F]AlF-NOTA-PCP2

Drug Alias Name18F-AlF-NOTA-PCP2

ClassificationRadiation-emitting products > Nuclides > Fluorine > 18FRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Radionuclide Drug Conjugates

Mechanisms of ActionProgrammed death-ligand 1 binders

TargetsProgrammed death-ligand 1

Therapy Area/IndicationsCarcinoma, Non-Small-Cell LungEsophageal NeoplasmsSquamous Cell Carcinoma of Head and Neck +[4]

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaPhase 2 Clinical

Originator CompaniesShandong First Medical University

China Registration ClassN/A

Develop Information

Active CompaniesShandong First Medical University

Inactive CompaniesN/A

Active IndicationsCarcinoma, Non-Small-Cell LungEsophageal NeoplasmsSquamous Cell Carcinoma of Head and Neck +[4]

Inactive IndicationsN/A

Other Information

ATC CodeN/A